insights_auto
Why is SOBI up २.३९%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK ४३७.४०
arrow_upward
+२.३९%(+१०.२०) 1D
अक्टोबर १४, १७:२९:५९ GMT+२ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK ४२७.४०
High
SEK ४३८.००
Low
SEK ४२४.८०
Mkt. cap
१.५६ खरब
Avg. vol.
२.५६ लाख
Volume
३.६० लाख
P/E ratio
११६.८२
52-wk high
SEK ४८७.००
52-wk low
SEK २९३.६०
EPS
SEK ३.७४
Shares outstanding
३५.७६ करोड
No. of employees
२ हजार
Open
SEK ४२७.४०
High
SEK ४३८.००
Low
SEK ४२४.८०
Mkt. cap
१.५६ खरब
Avg. vol.
२.५६ लाख
Volume
३.६० लाख
P/E ratio
११६.८२
52-wk high
SEK ४८७.००
52-wk low
SEK २९३.६०
EPS
SEK ३.७४
Shares outstanding
३५.७६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
MarketBeat
·
२० मिनेट पहिले
Terrestrial Energy (NASDAQ:IMSR) CEO Acquires $50,869.00 in Stock
Reuters
·
२ घण्टा पहिले
Wall St opens lower after hot CPI data fuels rate-hike bets
AP News
·
४७ मिनेट पहिले
Inflation worsened last month to 3.7% in sign that prices remain elevated as midterm elections near
The Motley Fool
·
३ घण्टा पहिले
The S&P 500 Is Dangerously Concentrated in 5 Tech Giants. Are They Still Buys?
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)